Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

CSU secures $3.1 million from NIH to advance SolaVAX coronavirus vaccine research

EurekAlert! - 21 Sep 2020 06:00
(Colorado State University) SolaVAX repurposes a commercial platform that is currently used to inactivate pathogens in blood transfusions.
Full Article at EurekAlert!

More Medical News
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard